News

Abstract: The minimum-mean-square-error approximation to a generalized minimum-shift-keying (MSK) signal using an offset quadrature phase-shift keying waveform with ...
Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about ...
Dr. Omar H. Llaguna, specialist in surgical oncology, programs a HistoSonics medical device for targeting a medium that ...
XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and can be Targeted to Overcome Chemoresistance - ...
Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...
Hinge Health, which just went public last month, launched a referral network of in-person providers to complement its virtual ...
Justin Taylor, M.D., a physician-scientist at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller ...
Justin Taylor, M.D. , a physician-scientist at Sylvester Comprehensive Cancer Center , part of the University of ...
CEPHEUS trial lead investigator Saad Z. Usmani, MD, MBA, FACP, FASCO, explains how the trial both builds on current knowledge of newly diagnosed multiple myeloma and how transplant-ineligible status ...
These findings are very important for patients with early-stage dMMR tumors because it’s likely they do not need surgery or radiation if they are treated first with immunotherapy for a sufficient ...
Hinge Health, Inc. (NYSE:HNGE), today announced the launch of HingeSelect, a high-performance provider network for ...